Biotech Stocks Icon

Biotech Stocks

Biotech is defined as using technology to change, manipulate, and harness biological processes in order to fulfill a medical need. The applications of biotech are endless and range from genetically modifying foods to creating vaccines. During the height of the coronavirus pandemic, companies like Moderna and BioNTech utilized biotech to create life-saving vaccines that were distributed across the globe.

Recent Biotech Stocks Articles

The 3 Most Undervalued Biotech Stocks to Buy: November 2023

Given the undervalued biotech industry, these three undervalued biotech stocks to buy are ripe purchase targets for high-potential profits.

Why Is Alaunos Therapeutics (TCRT) Stock Up 14% Today?

Alaunos Therapeutics stock is on the rise Tuesday as TCRT investors react to a mixed earnings report for the third quarter of 2023.

3 Cutting-Edge Biotech Stocks for the Bold Investor

Ahead of what could be significant uncertainties in the market, investors may be better served with cutting-edge biotech stocks. Fundamentally, the reasoning centers on relative…

3 of the Best Cheap Stocks Under $20 to Buy Now: November Edition

After dropping to 52-week lows, the markets have been rallying, sending traders and investors are looking for cheap stocks under $20.

Why Is Tenax Therapeutics (TENX) Stock Up 300% Today?

Although Tenax Therapeutics has received a green light for its investigational drug, investors should exercise caution with TENX stock.

Debt-Fueled Buybacks: 3 Stocks Undeterred by Rising Rates

Share repurchases have slowed in 2023, partly due to the 1% tax. Here are three buybacks partially paid for with debt offerings.

Why Is Tracon Pharmaceuticals (TCON) Stock Down 22% Today?

TCON stock is falling on Monday as the company's shares give up their gains from an earnings rally on Friday.

Why Is Verve Therapeutics (VERV) Stock Down 39% Today?

Verve Therapeutics stock is falling on Monday even after the company posted promising interim data from a Phase 1b clinical trial.

The Magnificent Seven: 7 Stocks That Could Make It the ‘Elite Eight’

Investors curious to identify the next magnificent 7 stock should start here as the clues are fairly straightforward

3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024

Investors should consider these "Goldilocks" biotech stocks to buy as they are poised to get significant boosts next year.

Why Is Tracon Pharmaceuticals (TCON) Stock Up 130% Today?

Tracon Pharmaceuticals stock is rising higher on Friday with heavy trading of TCON despite the company missing estimates in Q3 2023.

7 Biotech Stocks to Buy for Big-Time Gains

Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.

7 Underappreciated Biotech Stocks to Pick Up on the Cheap

Amid some rising questions for the economy, value-seeking investors may want to consider underappreciated biotech stocks. As a sector that, while not immune to broader…

Under the Microscope: 3 Biotech Stocks Pioneering Tomorrow’s Cures

Unveil the resilience of biotech stocks as they outsmart market trends and champion the race for tomorrow's treatments.

3 Biotech Stocks That Are Betting on the Future of Gene Editing 

These three companies have gene editing therapies in late-stage clinical trials, making them promising biotech stocks to buy right now.

7 Healthcare Stocks That Are Poised to Become the Next Unicorns

Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.

Why Is Assertio (ASRT) Stock Down 39% Today?

Assertio stock is dropping on Thursday as investors in ASRT react to the company's poor earnings results for the third quarter of 2023.

Why Is Atara Biotherapeutics (ATRA) Stock Down 50% Today?

Atara Biotherapeutics stock is falling on Thursday as investors in ATRA react to the company's latest Phase 2 clinical trial data.

Why Is JanOne (JAN) Stock Up 40% Today?

JanOne stock is climbing higher on Thursday with heavy trading of JAN shares despite a lack of news from the biopharmaceutical company.